Focused on therapies for women's cancers, this clinical-stage biotech reported a significant insider sale amid a year of ...
Multiple analyst upgrades, led by Wolfe Research and Wells Fargo, have pushed Elevance Health (ELV) into focus as investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback